CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increase in focus on enteral nutrition
4.1.2. The rise in demand for nutritional food from homecare sector
4.1.3. Growing prevalence of cancer
4.2. Market Restraints & Challenges
4.2.1. Complications associated with tube feeding
4.2.2. Limited reimbursement associated with its use
4.3. Market Opportunities
4.3.1. Growing importance of nutritional interventions
4.3.2. Increase in clinical research to improve the quality of life of patients
CHAPTER 5. GLOBAL ONCOLOGY NUTRITION MARKET – BY TYPE OF
CANCER
5.1. Head and Neck Cancer
5.2. Stomach and Gastrointestinal Cancers
5.3. Liver Cancer
5.4. Pancreatic Cancer
5.5. Oesophageal Cancer
5.6. Lung Cancer
5.7. Breast Cancer
5.8. Blood Cancer
5.9. Other Cancers
CHAPTER 6. GLOBAL ONCOLOGY NUTRITION MARKET - BY GEOGRAPHY
6.1. Introduction
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.2.3. Mexico
6.2.4. Costa Rica
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.3.3. Chile
6.3.4. Columbia
6.3.5. Others
6.4. Europe
6.4.1. U.K.
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Netherlands
6.4.8. Switzerland
6.4.9. Poland
6.4.10. Others
6.5. APAC
6.5.1. China
6.5.2. Japan
6.5.3. India
6.5.4. South Korea
6.5.5. Australia & New Zealand
6.5.6. Malaysia
6.5.7. Singapore
6.5.8. Others
6.6. Middle East & Africa
6.6.1. UAE
6.6.2. Saudi Arabia
6.6.3. Iran
6.6.4. Iraq
6.6.5. Qatar
6.6.6. South Africa
6.6.7. Algeria
6.6.8. Morocco
6.6.9. Nigeria
6.6.10. Egypt
6.6.11. Others
CHAPTER 7. GLOBAL ONCOLOGY NUTRITION MARKET - COMPANY
PROFILES
7.1. Abbott Laboratories
7.2. Nestle S.A
7.3. Danone
7.4. Fresenius Kabi Global
7.5. Braun Melsungen AG
7.6. Hormel Food Corporation
7.7. Global Health Products, Inc.
7.8. Meiji Holdings Co., Ltd.
7.9. Mead Johnson & Company, LLC.
7.10. Victus
7.11. Enlivity
7.12. Advanced Medical Nutrition
7.13. Pfizer, Inc.
CHAPTER 8. GLOBAL ONCOLOGY NUTRITION MARKET - COMPETITIVE
LANDSCAPE
8.1. Market Share Analysis
8.2. Strategies adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 9. MARKET INSIGHTS
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
CHAPTER 10. APPENDIX
10.1. List of Tables
10.2. List of Figures
